These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 8538022

  • 1. [Mechanisms for inactivation of tumor suppressor genes].
    Ishizaki K.
    Nihon Rinsho; 1995 Nov; 53(11):2660-5. PubMed ID: 8538022
    [Abstract] [Full Text] [Related]

  • 2. Alterations of tumor suppressor genes in bladder cancer.
    Cordon-Cardo C, Reuter VE.
    Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
    [Abstract] [Full Text] [Related]

  • 3. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
    Isfort RJ, Cody DB, Lovell GJ, Gioeli D, Weissman BE, Doersen CJ.
    Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
    [Abstract] [Full Text] [Related]

  • 4. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P.
    Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152
    [Abstract] [Full Text] [Related]

  • 5. Cancer risks from germ line tumor suppressor gene mutations.
    Frebourg T, Malkin D, Friend S.
    Princess Takamatsu Symp; 1991 Aug 01; 22():61-70. PubMed ID: 1844252
    [Abstract] [Full Text] [Related]

  • 6. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
    Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Ali IU.
    Cancer Res; 1992 Dec 01; 52(23):6716-21. PubMed ID: 1358438
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T, Tsunoda S, Sakaki T, Konishi N, Hiasa Y, Nakamura M.
    Cancer; 1996 Jul 15; 78(2):287-93. PubMed ID: 8674005
    [Abstract] [Full Text] [Related]

  • 9. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression.
    Ruggeri B, Caamano J, Goodrow T, DiRado M, Bianchi A, Trono D, Conti CJ, Klein-Szanto AJ.
    Cancer Res; 1991 Dec 15; 51(24):6615-21. PubMed ID: 1742735
    [Abstract] [Full Text] [Related]

  • 10. [Tumor suppressor genes: mutations in RB and p53 genes are significant carcinogenic factors].
    Wiman KG.
    Lakartidningen; 1992 Sep 23; 89(39):3169-74. PubMed ID: 1405928
    [Abstract] [Full Text] [Related]

  • 11. Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer.
    Semczuk A, Marzec B, Roessner A, Jakowicki JA, Wojcierowski J, Schneider-Stock R.
    Virchows Arch; 2002 Dec 23; 441(6):577-83. PubMed ID: 12461615
    [Abstract] [Full Text] [Related]

  • 12. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
    Murakami Y, Hayashi K, Hirohashi S, Sekiya T.
    Cancer Res; 1991 Oct 15; 51(20):5520-5. PubMed ID: 1655254
    [Abstract] [Full Text] [Related]

  • 13. Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma.
    Piao Z, Kim H, Jeon BK, Lee WJ, Park C.
    Cancer; 1997 Sep 01; 80(5):865-72. PubMed ID: 9307185
    [Abstract] [Full Text] [Related]

  • 14. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.
    Miyamoto H, Shuin T, Ikeda I, Hosaka M, Kubota Y.
    J Urol; 1996 Apr 01; 155(4):1444-7. PubMed ID: 8632608
    [Abstract] [Full Text] [Related]

  • 15. Tumor suppressor gene alterations in bladder carcinoma. Translational correlates to clinical practice.
    Dalbagni G, Cordon-Cardo C, Reuter V, Fair WR.
    Surg Oncol Clin N Am; 1995 Apr 01; 4(2):231-40. PubMed ID: 7796283
    [Abstract] [Full Text] [Related]

  • 16. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
    Havrilesky LJ, Alvarez AA, Whitaker RS, Marks JR, Berchuck A.
    Gynecol Oncol; 2001 Dec 01; 83(3):491-500. PubMed ID: 11733961
    [Abstract] [Full Text] [Related]

  • 17. The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression.
    Borg A, Zhang QX, Alm P, Olsson H, Sellberg G.
    Cancer Res; 1992 May 15; 52(10):2991-4. PubMed ID: 1581913
    [Abstract] [Full Text] [Related]

  • 18. The p53 tumor suppressor gene and gene product.
    Levine AJ.
    Princess Takamatsu Symp; 1989 May 15; 20():221-30. PubMed ID: 2488233
    [Abstract] [Full Text] [Related]

  • 19. Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias.
    Corradini P, Inghirami G, Astolfi M, Ladetto M, Voena C, Ballerini P, Gu W, Nilsson K, Knowles DM, Boccadoro M.
    Leukemia; 1994 May 15; 8(5):758-67. PubMed ID: 8182933
    [Abstract] [Full Text] [Related]

  • 20. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
    Stratton MR, Moss S, Warren W, Patterson H, Clark J, Fisher C, Fletcher CD, Ball A, Thomas M, Gusterson BA.
    Oncogene; 1990 Sep 15; 5(9):1297-301. PubMed ID: 2216456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.